DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Butylphthalide is an investigational drug.
There have been 15 clinical trials for Butylphthalide. The most recent clinical trial was a Phase 3 trial, which was initiated on May 5th 2019.
The most common disease conditions in clinical trials are Stroke, Ischemia, and Cerebral Infarction. The leading clinical trial sponsors are CSPC-NBP Pharmaceutical Co., Ltd., Peking Union Medical College Hospital, and The Second Hospital of Hebei Medical University.
Recent Clinical Trials for Butylphthalide
|NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy||CSPC-NBP Pharmaceutical Co., Ltd.||Phase 2|
|NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy||Conjupro Biotherapeutics, Inc.||Phase 2|
|NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events||Peking University International Hospital||Phase 3|